Harrington P - Search Results

1

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.

Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, Rossing MA, Duerst M, Dork T, Bogdanova NV, Modugno F, Moysich K, Odunsi K, Ness R, Karlan BY, Lester J, Jensen A, Krüger Kjaer S, Høgdall E, Campbell IG, Lázaro C, Pujara MA, Cunningham J, Vierkant R, Winham SJ, Hildebrandt M, Huff C, Li D, Wu X, Yu Y, Permuth JB, Levine DA, Schildkraut JM, Riggan MJ, Berchuck A, Webb PM, Group OS, Cybulski C, Gronwald J, Jakubowska A, Lubinski J, Alsop J, Harrington P, Chan I, Menon U, Pearce CL, Wu AH, de Fazio A, Kennedy CJ, Goode E, Ramus S, Gayther S, Pharoah P. Song H, et al. Among authors: harrington p. J Med Genet. 2021 May;58(5):305-313. doi: 10.1136/jmedgenet-2019-106739. Epub 2020 Jun 16. J Med Genet. 2021. PMID: 32546565 Free PMC article.

2

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.

Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, Love R, Evans G, Easton D, Clayton D, Stratton MR, Ponder BA. Gayther SA, et al. Among authors: harrington pa. Nat Genet. 1995 Dec;11(4):428-33. doi: 10.1038/ng1295-428. Nat Genet. 1995. PMID: 7493024

3

Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.

Gayther SA, Harrington P, Russell P, Kharkevich G, Garkavtseva RF, Ponder BA. Gayther SA, et al. Among authors: harrington p. Am J Hum Genet. 1996 Mar;58(3):451-6. Am J Hum Genet. 1996. PMID: 8644703 Free PMC article.

4

Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.

Foster KA, Harrington P, Kerr J, Russell P, DiCioccio RA, Scott IV, Jacobs I, Chenevix-Trench G, Ponder BA, Gayther SA. Foster KA, et al. Among authors: harrington p. Cancer Res. 1996 Aug 15;56(16):3622-5. Cancer Res. 1996. PMID: 8705994

5

Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.

Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS. Ramus SJ, et al. Among authors: harrington pa. Genes Chromosomes Cancer. 1999 Jun;25(2):91-6. doi: 10.1002/(sici)1098-2264(199906)25:2<91::aid-gcc3>3.0.co;2-5. Genes Chromosomes Cancer. 1999. PMID: 10337991

6

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA. Gayther SA, et al. Among authors: harrington p. Am J Hum Genet. 1999 Oct;65(4):1021-9. doi: 10.1086/302583. Am J Hum Genet. 1999. PMID: 10486320 Free PMC article.

7

BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.

Ramus SJ, Pharoah PD, Harrington P, Pye C, Werness B, Bobrow L, Ayhan A, Wells D, Fishman A, Gore M, DiCioccio RA, Piver MS, Whittemore AS, Ponder BA, Gayther SA. Ramus SJ, et al. Among authors: harrington p. Cancer Res. 2003 Jan 15;63(2):417-23. Cancer Res. 2003. PMID: 12543797

8

Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Werness BA, Ramus SJ, DiCioccio RA, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, Tsukada Y, Harrington P, Gayther SA, Ponder BA, Piver MS. Werness BA, et al. Among authors: harrington p. Int J Gynecol Pathol. 2004 Jan;23(1):29-34. doi: 10.1097/01.pgp.0000101083.35393.cd. Int J Gynecol Pathol. 2004. PMID: 14668547

9

Common polymorphisms in the prostaglandin pathway genes and their association with breast cancer susceptibility and survival.

Abraham JE, Harrington P, Driver KE, Tyrer J, Easton DF, Dunning AM, Pharoah PD. Abraham JE, et al. Among authors: harrington p. Clin Cancer Res. 2009 Mar 15;15(6):2181-91. doi: 10.1158/1078-0432.CCR-08-0716. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276290

10

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.

Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, Whittemore AS, Sutphen R, Phelan C, Anton-Culver H, Pearce CL, Lambrechts D, Rossing MA, Chang-Claude J, Moysich KB, Goodman MT, Dörk T, Nevanlinna H, Ness RB, Rafnar T, Hogdall C, Hogdall E, Fridley BL, Cunningham JM, Sieh W, McGuire V, Godwin AK, Cramer DW, Hernandez D, Levine D, Lu K, Iversen ES, Palmieri RT, Houlston R, van Altena AM, Aben KK, Massuger LF, Brooks-Wilson A, Kelemen LE, Le ND, Jakubowska A, Lubinski J, Medrek K, Stafford A, Easton DF, Tyrer J, Bolton KL, Harrington P, Eccles D, Chen A, Molina AN, Davila BN, Arango H, Tsai YY, Chen Z, Risch HA, McLaughlin J, Narod SA, Ziogas A, Brewster W, Gentry-Maharaj A, Menon U, Wu AH, Stram DO, Pike MC; Wellcome Trust Case-Control Consortium; Beesley J, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group; Ovarian Cancer Association Consortium (OCAC); Chen X, Ekici AB, Thiel FC, Beckmann MW, Yang H, Wentzensen N, Lissowska J, Fasching PA, D… See abstract for full author list ➔ Goode EL, et al. Among authors: harrington p. Nat Genet. 2010 Oct;42(10):874-9. doi: 10.1038/ng.668. Epub 2010 Sep 19. Nat Genet. 2010. PMID: 20852632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

549 results

Search Page